| Product Code: ETC13312815 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Drug Repurposing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Drug Repurposing Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Drug Repurposing Market - Industry Life Cycle |
3.4 Middle East Drug Repurposing Market - Porter's Five Forces |
3.5 Middle East Drug Repurposing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.7 Middle East Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Middle East Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Middle East Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Middle East Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Drug Repurposing Market Trends |
6 Middle East Drug Repurposing Market, 2021 - 2031 |
6.1 Middle East Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Drug Repurposing Market, Revenues & Volume, By On-Target Repurposing, 2021 - 2031 |
6.1.3 Middle East Drug Repurposing Market, Revenues & Volume, By Off-Target Repurposing, 2021 - 2031 |
6.1.4 Middle East Drug Repurposing Market, Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031 |
6.1.5 Middle East Drug Repurposing Market, Revenues & Volume, By Pathway-Based Repurposing, 2020 - 2028 |
6.2 Middle East Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Drug Repurposing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Middle East Drug Repurposing Market, Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031 |
6.2.4 Middle East Drug Repurposing Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.5 Middle East Drug Repurposing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3 Middle East Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Drug Repurposing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.3.3 Middle East Drug Repurposing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.3.4 Middle East Drug Repurposing Market, Revenues & Volume, By Academic Research Institutes, 2021 - 2031 |
6.3.5 Middle East Drug Repurposing Market, Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031 |
6.4 Middle East Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Drug Repurposing Market, Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031 |
6.4.3 Middle East Drug Repurposing Market, Revenues & Volume, By High-Throughput Screening, 2021 - 2031 |
6.4.4 Middle East Drug Repurposing Market, Revenues & Volume, By Biomarker-Based Repurposing, 2020 - 2028 |
6.4.5 Middle East Drug Repurposing Market, Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2020 - 2028 |
7 Middle East Drug Repurposing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.1 Saudi Arabia Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.2 UAE Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.3 Kuwait Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.4 Qatar Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.5 Bahrain Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.6 Oman Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.7 Turkey Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.8 Rest of Middle East Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.3 Middle East Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
7.3.1 Saudi Arabia Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.2 UAE Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.3 Kuwait Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.4 Qatar Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.5 Bahrain Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.6 Oman Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.7 Turkey Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.8 Rest of Middle East Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.4 Middle East Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 Saudi Arabia Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 UAE Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Kuwait Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Qatar Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Bahrain Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Oman Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.7 Turkey Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.8 Rest of Middle East Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Middle East Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 Saudi Arabia Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 UAE Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 Kuwait Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.4 Qatar Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.5 Bahrain Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.6 Oman Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.7 Turkey Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.8 Rest of Middle East Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Middle East Drug Repurposing Market Key Performance Indicators |
9 Middle East Drug Repurposing Market - Export/Import By Countries Assessment |
10 Middle East Drug Repurposing Market - Opportunity Assessment |
10.1 Middle East Drug Repurposing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
10.3 Middle East Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
10.4 Middle East Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Middle East Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Middle East Drug Repurposing Market - Competitive Landscape |
11.1 Middle East Drug Repurposing Market Revenue Share, By Companies, 2022 |
11.2 Middle East Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here